Non Invasive Prenatal Testing Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
Non-invasive prenatal testing (NIPT) represents a groundbreaking advancement in prenatal screening, enabling the detection of specific genetic abnormalities in a developing fetus without resorting to invasive methods like amniocentesis or chorionic villus sampling. NIPT works by analyzing cell-free DNA (cfDNA) in the mother's bloodstream, which includes genetic material from both the mother and the fetus. This allows healthcare professionals to evaluate the risk of chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13.
Non Invasive Prenatal Testing Market Regional AnalysisCHAPTER 1. Industry Overview of Non Invasive Prenatal Testing Market
1.1. Definition and Scope
1.1.1. Definition of Non Invasive Prenatal Testing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Non Invasive Prenatal Testing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Non Invasive Prenatal Testing Market By Component
1.2.3. Non Invasive Prenatal Testing Market By Application
1.2.4. Non Invasive Prenatal Testing Market By End User
1.2.5. Non Invasive Prenatal Testing Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Non Invasive Prenatal Testing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Non Invasive Prenatal Testing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Non Invasive Prenatal Testing Market By Component
5.1. Introduction
5.2. Non Invasive Prenatal Testing Revenue By Component
5.2.1. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast, By Component, 2020-2032
5.2.2. Kits and Reagents
5.2.2.1. Kits and Reagents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Instruments
5.2.3.1. Instruments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Services
5.2.4.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Non Invasive Prenatal Testing Market By Application
6.1. Introduction
6.2. Non Invasive Prenatal Testing Revenue By Application
6.2.1. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast, By Application, 2020-2032
6.2.2. Down Syndrome (trisomy 21)
6.2.2.1. Down Syndrome (trisomy 21) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Patau Syndrome (trisomy 13)
6.2.3.1. Patau Syndrome (trisomy 13) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Edwards Syndrome (trisomy 18)
6.2.4.1. Edwards Syndrome (trisomy 18) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Turner Syndrome
6.2.5.1. Turner SyndromeMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Non Invasive Prenatal Testing Market By End User
7.1. Introduction
7.2. Non Invasive Prenatal Testing Revenue By End User
7.2.1. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast, By End User, 2020-2032
7.2.2. Diagnostic Labs
7.2.2.1. Diagnostic Labs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Hospitals
7.2.3.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Non Invasive Prenatal Testing Market By Country
8.1. North America Non Invasive Prenatal Testing Market Overview
8.2. U.S.
8.2.1. U.S. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
8.2.2. U.S. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.S. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
8.3. Canada
8.3.1. Canada Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
8.3.2. Canada Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Canada Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Non Invasive Prenatal Testing Market By Country
9.1. Europe Non Invasive Prenatal Testing Market Overview
9.2. U.K.
9.2.1. U.K. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
9.2.2. U.K. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. U.K. Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Germany
9.3.1. Germany Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
9.3.2. Germany Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Germany Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. France
9.4.1. France Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
9.4.2. France Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. France Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.5. Spain
9.5.1. Spain Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
9.5.2. Spain Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Spain Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
9.6.2. Rest of Europe Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Non Invasive Prenatal Testing Market By Country
10.1. Asia Pacific Non Invasive Prenatal Testing Market Overview
10.2. China
10.2.1. China Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.2.2. China Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. China Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Japan
10.3.1. Japan Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.3.2. Japan Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Japan Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. India
10.4.1. India Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.4.2. India Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. India Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Australia
10.5.1. Australia Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.5.2. Australia Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.3. Australia Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.6. South Korea
10.6.1. South Korea Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.6.2. South Korea Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.3. South Korea Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
10.7.2. Rest of Asia-Pacific Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Non Invasive Prenatal Testing Market By Country
11.1. Latin America Non Invasive Prenatal Testing Market Overview
11.2. Brazil
11.2.1. Brazil Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
11.2.2. Brazil Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. Brazil Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. Mexico
11.3.1. Mexico Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
11.3.2. Mexico Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. Mexico Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
11.4.2. Rest of Latin America Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Non Invasive Prenatal Testing Market By Country
12.1. Middle East & Africa Non Invasive Prenatal Testing Market Overview
12.2. GCC
12.2.1. GCC Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
12.2.2. GCC Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.3. GCC Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.3. South Africa
12.3.1. South Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
12.3.2. South Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.3. South Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Component, 2020-2032
12.4.2. Rest of Middle East & Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Non Invasive Prenatal Testing Revenue (USD Billion) and Forecast By End User, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Non Invasive Prenatal Testing Market
13.1. Non Invasive Prenatal Testing Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Non Invasive Prenatal Testing Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Centogene N.V.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Centogene N.V. 2022 Non Invasive Prenatal Testing Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Genesis Genetics
14.3. Eurofins LifeCodexx GmbH
14.4. Natera, Inc.
14.5. Quest Diagnostics, Inc.
14.6. F. Hoffmann-La Roche Ltd.
14.7. Illumina, Inc.
14.8. Qiagen
14.9. MedGenome Labs Ltd.
14.10. Laboratory Corp. of America Holdings
14.11. Myriad Women’s Health, Inc.
14.12. Progenity, Inc.
Frequently Asked Questions
How big is the non invasive prenatal testing market?
The non invasive prenatal testing market size was USD 4.5 Billion in 2022.
What is the CAGR of the global non invasive prenatal testing market from 2023 to 2032?
The CAGR of non invasive prenatal testing is 11.6% during the analysis period of 2023 to 2032.
Which are the key players in the non invasive prenatal testing market?
The key players operating in the global market are including Centogene N.V., Genesis Genetics, Eurofins LifeCodexx GmbH, Natera, Inc., Quest Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Qiagen, MedGenome Labs Ltd., Laboratory Corp. of America Holdings, Myriad Women’s Health, Inc., and Progenity, Inc.
Which region dominated the global non invasive prenatal testing market share?
North America held the dominating position in non invasive prenatal testing industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of non invasive prenatal testing during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global non invasive prenatal testing industry?
The current trends and dynamics in the non invasive prenatal testing industry include increasing maternal age and awareness of genetic disorders, technological advancements improving test accuracy and reliability, and non-invasive nature reduces procedural risks for pregnant women.
Which application held the maximum share in 2022?
The down syndrome application held the maximum share of the non invasive prenatal testing industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
